AngioDynamics
ANGO
174 hedge funds and large institutions have $810M invested in AngioDynamics in 2018 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 60 increasing their positions, 56 reducing their positions, and 13 closing their positions.
235% more call options, than puts
Call options by funds: $295K | Put options by funds: $88K
92% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 13
29% more capital invested
Capital invested by funds: $626M → $810M (+$184M)
6% more funds holding
Funds holding: 164 → 174 (+10)
7% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 56
0.22% more ownership
Funds ownership: 98.78% → 99.01% (+0.22%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lazard Asset Management
New York
|
+$12.4M |
| 2 |
TCM
Tributary Capital Management
Omaha,
Nebraska
|
+$8.2M |
| 3 |
BlackRock
New York
|
+$7.66M |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
+$4M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$3.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
-$15.7M |
| 2 |
RA
Royce & Associates
New York
|
-$6.88M |
| 3 |
FWIA
Fort Washington Investment Advisors
Cincinnati,
Ohio
|
-$4.6M |
| 4 |
Millennium Management
New York
|
-$3.79M |
| 5 |
GLA
Great Lakes Advisors
Chicago,
Illinois
|
-$3.19M |
ANGO Hedge Fund Activity: Q2 2018 in Review
174 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q2 2018, worth a combined $810M — up 29% from $626M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new ANGO positions and 13 closed out — a net gain of 12 holders — while 60 added to existing stakes and 56 trimmed.
The largest buyer was Lazard Asset Management, opening a new position worth an estimated $12.4M. The largest seller was Broadfin Capital, exiting entirely with an estimated $15.7M sold.
- 174 institutional investors held AngioDynamics (ANGO) as of Q2 2018, up from 164 in Q1 2018.
- Funds reported $810M of AngioDynamics stock for Q2 2018, up 29% quarter-over-quarter.
- 25 funds opened new AngioDynamics positions in Q2 2018 and 13 closed out, a net change of +12 holders.
- The largest AngioDynamics buyer in Q2 2018 was Lazard Asset Management, an estimated $12.4M added.
- The largest AngioDynamics seller in Q2 2018 was Broadfin Capital, an estimated $15.7M sold.
Based on aggregated 13F filings for Q2 2018.